A 'best practices' approach to neuropathologic assessment in developmental neurotoxicity testing--for today.
A key trait of developmental neurotoxicants is their ability to cause structural lesions in the immature nervous system. Thus, neuropathologic assessment is an essential element of developmental neurotoxicity (DNT) studies that are designed to evaluate chemically-induced risk to neural substrates in young humans. The guidelines for conventional DNT assays have been established by regulatory agencies to provide a flexible scaffold for conducting such studies; recent experience has launched new efforts to update these recommendations. The present document was produced by an ad hoc subcommittee of the Society of Toxicologic Pathology (STP) tasked with examining conventional methods used in DNT neuropathology in order to define the 'best practices' for dealing with the diverse requirements of both national (EPA) and international (OECD) regulatory bodies. Recommendations (including citations for relevant neurobiological and technical references) address all aspects of the DNT neuropathology examination: study design; tissue fixation, collection, processing, and staining; qualitative and quantitative evaluation; statistical analysis; proper control materials; study documentation; and personnel training. If followed, these proposals will allow pathologists to meet the need for a sound risk assessment (balanced to address both regulatory issues and scientific considerations) in this field today while providing direction for the research needed to further refine DNT neuropathology 'best practices' in the future.
Bolon
Brad
B
GEMpath Inc., Cedar City, Utah 84720, USA.
Garman
Robert
R
Jensen
Karl
K
Krinke
Georg
G
Stuart
Barry
B
D000818:Animals; D019985:Benchmarking; D005260:Female; D006652:Histological Techniques / Q000379:methods; D006801:Humans; D009420:Nervous System / Q000033:anatomy & histology; D009422:Nervous System Diseases / Q000139:chemically induced* / Q000473:pathology*; D009462:Neurology / Q000379:methods*; D020258:Neurotoxicity Syndromes / Q000151:congenital; D010336:Pathology / Q000379:methods*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D012107:Research Design